TENX

$1.79-3.76%visit website

TENAX THERAPEUTICS, INC.

Market Cap

$47M

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.92

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Price / TTM revenue

P/B

0.4

Price / stockholders equity

EV/EBITDA

—

TTM

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Research & development	10,328	10,540	11,539	12,850	45,257
Selling, general & administrative				5,934
Total operating expenses	16,806	16,449	16,573	18,784	68,612
Operating income	(16,806)	(16,449)	(16,573)	(18,784)	(68,612)
Interest expense	0.00	0.00
Net income	(15,804)	(15,540)	(15,716)	(17,803)	(64,863)
EPS (basic) ($)	(0.40)		(0.35)	(0.35)	—
EPS (diluted) ($)	(0.40)		(0.35)	(0.35)	—
Weighted avg. shares (basic)	39,741		45,226	50,869
Weighted avg. shares (diluted)	39,741		45,226	50,869

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Jul 31, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 63 more quarters, back to Jul 2010, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

52%

W/W -15.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

26.39x

Avg Daily Buying (90d)

40,984 sh/day

Baseline Daily Buying

0.0 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-21	2026-10-21	ADAR1 Capital Management, LLC	10% Owner	Purchase	332.0K	$1.66	$551K	7.45M	View
2026-10-20	2026-10-21	ADAR1 Capital Management, LLC	10% Owner	Purchase	254.3K	$1.60	$406K	7.12M	View
2026-10-19	2026-10-21	ADAR1 Capital Management, LLC	10% Owner	Purchase	336.5K	$1.51	$507K	6.86M	View
2026-09-16	2026-09-17	Doogan Declan	Director	Purchase	53.0K	$1.92	$102K	55.3K	View
2026-09-15	2026-09-15	Giordano Christopher Thomas	Director & CEO	Purchase	4,850	$1.82	$9K	22.2K	View

1–5 of 14

1 / 3

Recent News

TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact SueWallSt

Morningstar · 2026-10-29

Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ

Timothy Sykes · 2026-10-28

BlackRock reports a passive stake in Tenax Therapeutics (TENX), with sole votes on 2.75M shares.

Stock Titan · 2026-10-27

Tenax Therapeutics (TENX) Stock Fair Value Falls After Cautious Analyst Calls On LEVEL Data

Yahoo · 2026-10-25

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 2026-10-21

Tenax Therapeutics Temporarily Pauses Enrollment In LEVEL-2 Trial Of TNX-103 To Amend Criteria; Requests FDA Meeting

Benzinga · 2026-10-08

Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?

Yahoo Finance · 2026-09-04

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Yahoo Finance · 2026-09-01

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

Yahoo Finance · 2026-08-29

Tenax rises on over $1.8M insider buying (TENX:NASDAQ)

Seeking Alpha · 2026-08-25

Tenax Therapeutics’ stock crashes on Phase III trial failure

Yahoo Finance · 2026-08-11

Tenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103

Yahoo Finance · 2026-08-10

Why Did TENX Stock Crash 89% Today?

Stocktwits · 2026-08-10

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Yahoo Finance · 2026-07-31

Should I buy Tenax Therapeutics (TENX)

Zacks Investment Research · 2026-07-21

Informational purposes only, not investment advice.

TENX

Financial Statements

Signals

Factor Profile

Recent News

TENAX THERAPEUTICS, INC. (TENX)

Reporting Insiders

Factor Profile

Date	Insider	Type	Shares	Value
2026-10-21	ADAR1 Capital Management, LLC	P	331,979	$550,686.77
2026-10-20	ADAR1 Capital Management, LLC	P	254,342	$405,726.36
2026-10-19	ADAR1 Capital Management, LLC	P	336,528	$507,013.08
2026-09-16	Doogan Declan	P	53,000	$101,760
2026-09-15	Giordano Christopher Thomas	P	4,850	$8,837.19